Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...

Medscape Medical News, September 02, 2019 ESC 2019 COMPLETE: Better Outcome With PCI in Nonculprit Lesions After STEMI New data show ... in ACS Patients on DAPT Should Prompt Cancer Search ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT ... Most cases of STEMI (ST elevation MI) are ...

"and further studies are needed to assess the efficacy and safety of the [two] short DAPT regimens in women and men with [STEMI] and with more anatomically complex disease." In an accompanying ...

STEMI was the cause of ACS in 44.4% of our patients. Clinicians initiated DAPT in 486 patients. 98.1% of all patients had PPI prescribed alongside DAPT. Lansoprazole was the most common PPI prescribed ...

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the US Food and Drug ...

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...

De-escalating from aspirin plus ticagrelor to aspirin plus clopidogrel 1 month post-percutaneous coronary intervention (PCI) was associated with favorable outcomes in patients with stabilized ...

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially among ...